Trinity Biotech Investor Relations Material
Latest events
Q3 2024
Trinity Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Trinity Biotech plc
Access all reports
Trinity Biotech plc. focuses on the development, manufacturing, and marketing of diagnostic products for the clinical laboratory and point-of-care segments. The company's product portfolio includes diagnostic tests for infectious diseases, diabetes, hemoglobin disorders, and autoimmune conditions. Trinity Biotech serves healthcare providers, laboratories, and patients worldwide, offering reliable and high-quality diagnostic solutions. The company is headquartered in Bray, Ireland, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
TRIB
Country
🇺🇸 United States